Ausgabe 9/2011
Inhalt (6 Artikel)
Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies
Petros Pechlivanoglou, Robin De Vries, Simon M.G.J. Daenen, Maarten J. Postma
Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
Alexander Goehler, Benjamin P. Geisler, Jennifer M. Manne, Beate Jahn, Annette Conrads-Frank, G. Scott Gazelle, Uwe Siebert
To Fund or Not to Fund
Tania Stafinski, Devidas Menon, Christopher McCabe, Donald J. Philippon
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
Naiyana Praditsitthikorn, Yot Teerawattananon, Sripen Tantivess, Supon Limwattananon, Arthorn Riewpaiboon, Saibua Chichareon, Nantakan Ieumwananonthachai, Viroj Tangcharoensathien